The Food and Drug Administration

[phkrause]

Sunscreen changes

For the first time in 20 years, the Food and Drug Administration approved a new sunscreen ingredient known as BEMT. Experts say it’s a safer option than many of the chemical additives currently used in the US.

[phkrause]

🚬 The FDA will allow Zyn nicotine pouches to be marketed as less harmful than cigarettes. Scientists generally agree the pouches are a safer option for smokers, but critics worry about their appeal to young people, Axios' Caitlin Owens first reported.

[phkrause]

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

WASHINGTON (AP) — A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven’t been shown to be safe or effective.

https://apnews.com/article/peptides-fda-rfk-kennedy-bpc157-tb500-7267d0fad0110e7c2ed301d03cf5f0c2?

[phkrause]

FDA Eases Restrictions On Compounded Peptides Despite Safety Warnings

An advisory panel for the Food and Drug Administration (FDA) convened on July 23–24 to discuss whether seven peptides should be added to a list of drugs that compounding pharmacies are allowed to manufacture.

https://www.healthline.com/health-news/compounded-peptides-eased-restrictions-fda?

[phkrause]

Flu vaccines

The FDA has approved the first mRNA-based flu vaccine in the US for adults 50 and older, drugmaker Moderna announced Wednesday. Unlike traditional flu shots, which require strains to be selected months in advance, the mRNA vaccine can be updated much closer to flu season, potentially making it a better match for circulating viruses. In Moderna's study of more than 40,000 adults 50 and older, the vaccine was about 27% more effective than standard flu shots last year. If rolled out as planned, Moderna said the vaccine will be available to eligible US adults for the 2026-27 respiratory virus season, which typically begins in October.   New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said. Read More.

[phkrause]

Faster Flu Shot

The Food and Drug Administration has approved the first mRNA flu vaccine for adults age 50 to 64, expanding a Nobel Prize-winning technology first used to combat COVID-19. Unlike traditional vaccines, which take several months to develop, mRNA vaccines can be produced in about six weeks and modified to match emerging flu strains.  Developed by Moderna, mFlusiva uses the mRNA plug-and-play model in which genetic sequences for any virus or pathogen can be swapped into the vaccine. Traditional vaccines require growing virus components, which limits the possibility of quick adaptation. The new vaccine coming this fall is 27% more effective than a standard flu shot, though clinical trial participants reported mild side effects like injection-site pain, fatigue, and headaches. Influenza ranks as the 11th leading cause of death in the US, and it results in over 300,000 deaths worldwide annually. Flu season typically runs from October to May in the US. Explore a map tracking reported cases of influenza-like illness here.

[phkrause]

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said.

https://apnews.com/article/flu-vaccine-moderna-mrna-fda-mflusiva-59d991a6bf70c26e2f0c210cc8ca87f1?